Clinical Psychopharmacology is a specialized field at the intersection of psychiatry and pharmacology, devoted to understanding the effects of psychotropic medications on mental health. This discipline plays a pivotal role in the treatment of various psychiatric disorders, offering interventions that target neurotransmitter systems to alleviate symptoms. Practitioners in clinical psychopharmacology utilize evidence-based approaches to prescribe and monitor the use of psychotropic drugs, tailoring treatments to individual patient needs. The field encompasses the study of a wide range of medications, including antidepressants, antipsychotics, anxiolytics, and mood stabilizers. Monitoring side effects and adjusting medication regimens based on individual responses are critical aspects of clinical psychopharmacology. Ethical considerations, informed consent, and a comprehensive understanding of psychopathology are integral to responsible practice in this field. The evolving landscape of neuroscience and pharmacology continually informs clinical psychopharmacology, allowing for the development of novel medications and personalized treatment approaches. Collaboration between mental health professionals, pharmacologists, and researchers is essential for advancing the field and improving outcomes for individuals grappling with mental health challenges.
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Emerging formulation and delivery applications of vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Antibody-proteases as translational tools of the next-step generation to be applied for biopharmacy-related and precision medical practice
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Storage stability and solution binding affinity of an fc-fusion mimetic
Hanieh Khalili, University of East London, United Kingdom
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia